Schizophrenia patients exhibit increased hippocampal activity that is correlated with positive symptoms. Although the cause of this hippocampal hyperactivity has not been demonstrated, it likely involves a decrease in GABAergic signaling. Thus, we posit that restoring GABAergic function may provide a novel therapeutic approach for the treatment of schizophrenia. It has been demonstrated that transplanted GABAergic precursor cells from the medial ganglionic eminence (MGE) can migrate and differentiate into mature interneurons. Here, we demonstrate that ventral hippocampal MGE transplants can restore hippocampal function and normalize downstream dopamine neuron activity in a rodent model of schizophrenia. Furthermore, MGE transplants also reverse the hyper-responsive locomotor response to amphetamine. Taken together, these data demonstrate that restoring interneuron function reverses neurophysiological and behavioral deficits in a rodent model of schizophrenia and moreover, demonstrate the feasibility of a neuronal transplant procedure as a potential novel therapeutic approach for the treatment of schizophrenia.
INTRODUCTION
One of the oldest hypotheses of schizophrenia, the dopamine hypothesis, suggests that hyperactivity within the mesolimbic dopamine system underlies positive symptoms associated with the disease. 1, 2 As there is no apparent pathology within the dopamine neurons themselves, it is likely that the regulation of the dopamine system is altered in the disease. The hippocampus is one such region that is consistently implicated in schizophrenia. Specifically, hyperactivity within hippocampal subfields at rest is a consistent observation in both human imaging studies and preclinical rodent models. [3] [4] [5] [6] [7] Furthermore, this augmented hippocampal activity has been demonstrated to drive a dopamine system hyperfunction 3, 8, 9 that is correlated with positive symptoms in schizophrenia patients 7 and aberrant behavior in rodent models. 3, 8 The exact cause of the hippocampal hyperactivity is not currently known; however, we posit that it may be explained by a loss of GABAergic function, particularly in those fast-spiking, peri-somatic targeting interneurons identified by the calcium-binding protein parvalbumin (PV). Thus, postmortem studies in schizophrenia patients, 10 as well as in rodent models, 11, 12 display decreases in PV expression that correlate with alterations in coordinated neuronal activity. 11 Consequently, a more effective therapy may lie in restoring aberrant hippocampal function. We have demonstrated that pharmacological 13 or surgical (deep brain stimulation) 8 attenuation of ventral hippocampal (vHipp) activity effectively normalizes augmented dopamine neuron activity and reverses the increased locomotor response to amphetamine in the methylazoxymethanol acetate (MAM) rodent model of schizophrenia (for review see Ref. 14) . In addition, deep brain stimulation of the vHipp was also effective in reversing cognitive deficits in the MAM model. 8 Given that the increase in hippocampal activity is likely secondary to a pathological decrease in interneuron function, we posit that a more effective and potentially long-term therapy may be to replace dysfunctional interneurons. Cell-based therapies are now being studied for the treatment of neurological conditions that require an enhancement or modulation of GABAergic inhibition. Recent studies have used the use of medial ganglionic eminence (MGE)derived GABAergic precursor neurons as a means to increase inhibition in models of epilepsy and Parkinson's disease. [15] [16] [17] [18] When transplanted into an adult rodent brain, MGE-derived cells are able to migrate, differentiate into functional interneurons and make functional synapses with existing neurons to rescue deficits in GABAergic signaling. [15] [16] [17] [18] [19] [20] Taken together, we propose that transplantation of MGE-derived cells into the vHipp of MAMtreated rats will increase GABAergic signaling, thereby restoring aberrant hippocampal activity and normalizing augmented dopamine system function and behavior.
MATERIALS AND METHODS
All experiments were performed in accordance with the guidelines outlined in the United States Public Health Service Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Texas Health Science Center.
Cell transplantation surgeries
Survival surgeries were performed in a semisterile environment under general anesthesia. Male MAM-and saline-treated rats (40-45 days old; 150-250 g) were anesthetized with pentobarbital (60 mg kg À 1 , i.p.) and placed in a stereotaxic apparatus using blunt atraumatic ear bars. MGE cell transplants were performed by manual dissection of embryonic (gestational day 14.5) MGE-derived tissue from GFP þ transgenic rats (SD-Tg(GFP)2BalRrrc). MGE tissue was dissociated in Leibovitz L-15 medium (Sigma-Aldrich, St Louis, MO, USA) and bilaterally injected into the vHipp (A/P ± 4.8; M/L ± 4.8; D/V À 7.0 mm from bregma). A portion of the adjacent fetal brain tissue was repeatedly frozen and thawed to produce dead neurons for control transplants. Rats were housed for a minimum of 2 months following transplantation before any behavior or electrophysiology experiments were performed.
Extracellular recordings
MAM-and saline-treated rats (350-500 g) previously transplanted with MGE-derived cells were anesthetized with 8% chloral hydrate (400 mg kg À 1 , i.p.). Rats were placed in a stereotaxic apparatus and a core body temperature of 37 1C was maintained. Anesthesia was supplemented as required to maintain suppression of the limb compression withdrawal reflex. Extracellular glass microelectrodes (impedance 6-14 MO) were lowered into the vHipp (A/P ± 5.0; M/L ± 4.5; D/V À 4.0-À 8.0 mm from bregma) or ventral tegmental area (A/P ±5.3; M/L ±0.6; D/V À 6.5--À 9.0 mm from bregma). Putative pyramidal neurons were defined as those with firing o2 Hz. 9, 22, 23 Spontaneously active dopamine neurons were identified using previously established electrophysiological criteria. 24 Three parameters of dopamine neuron activity were measured: (1) population activity, (2) basal firing rate and (3) the proportion of action potentials occurring in bursts. Electrophysiological recordings were analyzed by a two-way analysis of variance (ANOVA) (strain and treatment as factors), followed by a Holm-Sidak post hoc test.
Amphetamine-induced hyperlocomotion
MAM-and saline-treated transplanted rats were placed in an open field arena (Med Associates, Georgia, VT, USA), and spontaneous locomotor activity in the x-y plane was determined for 45 min by beam breaks and recorded with Open Field Activity software (Med Associates). Immediately following the baseline recording, all rats were injected with increasing doses of D-amphetamine sulfate (0.5 mg kg À 1 followed by 2.0 mg kg À 1 , i.p.), and locomotor activity was recorded for an additional 45 min following each dose. Locomotor data were analyzed by three separate three-way ANOVA's (strain, treatment and time as factors), one for each of the relevant time periods (baseline, 0.5 mg kg À 1 , 2.0 mg kg À 1 ) followed by a Holm-Sidak post hoc test.
Immunohistochemistry
At the cessation of all experiments, rats were transcardially perfused with saline (100 ml), followed by formaldehyde (150 ml; 4% v/v in phosphatebuffered saline). Rats were decapitated and brains extracted, post-fixed for at least 24 h and cryoprotected (25% w/v sucrose in phosphate-buffered saline) until saturated. Brains were coronally sectioned (50 mm) using a cryostat (Leica, Buffalo Grove, IL, USA). Ventral hippocampal slices were used to detect the expression of PV and GAD65/67 within transplanted (green fluorescent protein, GFP positive) neurons. Slices were washed three times (10 min) in phosphate-buffered saline then blocked (2% normal goat serum and 0.3% Triton Tx100) for 30 min at room temperature. Primary antibodies (anti-PV 1:1000 (Abcam, Cambridge, MA, USA; ab11427) or anti-GAD65/67 1:1000 (Abcam; ab49832)) were applied (in phosphate-buffered saline containing 1% normal goat serum and 0.3% Triton Tx100) overnight at 4 1C followed by incubation with AlexaFluor 594 goat anti-rabbit immunoglobulin G (H þ L) for 1 h at room temperature. Slices were then mounted and cover slipped with ProLong gold anti-fade reagent.
Analysis
Electrophysiological analysis of dopamine neuron activity was performed with commercially available computer software (LabChart version 7.1; ADInstruments, Chalgrove, Oxfordshire, UK) and analyzed using Prism software (GraphPad Software, San Diego, CA, USA), whereas locomotor activity was collected with Activity Monitor (MED Associates). To confirm the phenotype of the transplanted neurons, cell counts of GFP þ cells or cells stained for PV or GAD65/67 were performed from images obtained from an AxioCam ICc 1 (Zeiss) camera on an Axio Lab.A1 microscope (Zeiss). GFP þ cells were counted from 4 to 8 vHipp coronal sections per animal. Representative images for Figure 1 were acquired using a confocal microscope (Zeiss 510 NLO) excited by an argon (458/488/514 nm; 25 mW) or green HeNe (543 nm, 1 mW) laser. Data are represented as the mean ± s.e.m. unless stated otherwise, with n values representing the number of animals per experimental group or number of neurons per group where indicated. Statistics were calculated using SigmaPlot (Systat Software Inc., Chicago, IL, USA).
Materials
MAM was purchased from Midwest Research Institute (Kansas City, MO, USA). Chloral hydrate, sodium pentobarbital sodium, Dulbecco's phosphate-buffered saline, Leibovitz L-15 medium, D-amphetamine sulfate and anti-GABA antibody (A2052) were all from Sigma. GFP þ transgenic rats (SD-Tg(GFP)2BalRrrc) were purchased from the Rat & Research Resource Center (donated by Carlos Lois-California Institute of Technology, Pasadena, CA, USA). The anti-PV (ab11427) and anti-GAD65/67 (ab49832) antibodies were from Abcam. AlexaFluor 596-conjugated anti-rabbit (A11012) and ProLong Gold antifade mountant were from Invitrogen (Grand Island, NY, USA). All other chemicals and reagents were of either analytical or laboratory grade and purchased from various suppliers.
RESULTS
Electrophysiology MAM-treated rats exhibit elevated vHipp firing rates which we posit is due to a decrease in the GABAergic signaling. 3, 9 To verify that MGE cell transplants alter vHipp activity, we recorded putative pyramidal cell activity throughout the vHipp (Figure 2) . Consistent with previous studies, 3, 8 MAM-treated control rats (bilaterally implanted with dead cells) display significantly higher firing rates (0.88 Hz±0.07, n ¼ 56) when compared with salinetreated controls (n ¼ 48; 0.55 Hz±0.08; two-way ANOVA; F Strain ¼ 6.33; F Treatment ¼ 11.11; F StrainxTreatment ¼ 4.47; Holm-Sidak; t ¼ 3.10; P ¼ 0.002). Saline-treated rats transplanted with live cells did not display a significant change in firing rate (0.46 Hz±0.06, n ¼ 74) when compared with saline-treated control rats (two-way ANOVA; Holm-Sidak; t ¼ 0.86; P ¼ 0.388). However, vHipp firing rates were normalized in MAM-treated rats transplanted with live MGE cells (n ¼ 59; 0.49 Hz±0.07) causing a significant decrease in the frequency when compared with MAM-treated controls (twoway ANOVA; Holm-Sidak; t ¼ 3.84; Po0.001).
In addition, MGE cell transplants caused downstream changes in dopamine neuron activity within the ventral tegmental area of MAM-treated rats. Saline-treated control rats (n ¼ 8) displayed an average of 0.96 ± 0.09 spontaneously active dopamine neurons per track consistent with previous findings in untreated rats. 3, 8, 9 MAM-treated control rats (n ¼ 7) had a significantly higher number of spontaneously active dopamine neurons (1.89 ± 0.10) when compared with saline-treated control rats (two-way ANOVA; F Strain ¼ 19.44; F Treatment ¼ 13.71; F StrainxTreatment ¼ 26.62; Holm Sidak; t ¼ 6.65; Po0.001), again consistent with previous observations. 3, 8 Consistent with the lack of effect on vHipp pyramidal cell activity, MGE cell transplants had no significant effect on dopamine neuron activity in saline-treated rats (n ¼ 8; 1.10 ± 0.09; two-way ANOVA; Holm-Sidak; t ¼ 0.87, P ¼ 0.388), but were able to normalize the aberrant ventral tegmental area dopamine neuron population activity observed in MAM-treated rats (n ¼ 8; 1.03±0.09; two-way ANOVA; Holm Sidak; t ¼ 6.16; Po0.001). MGE cell transplants also caused subtle changes in firing rates and bursting activity, not believed to be physiologically relevant, as those parameters are not dependent on, or altered by, inputs from the vHipp. 3 Amphetamine-induced hyperlocomotion MAM-treated control rats (n ¼ 12) display a significantly enhanced locomotor response to low dose (0.5 mg kg À 1 , i.p.) amphetamine administration when compared with saline-treated rats (n ¼ 12;
three-way ANOVA of 0.5 mg kg À 1 dose; F StrainxTreatment ¼ 30.94; Holm Sidak; t ¼ 3.84; Po0.001), as previously demonstrated (Figure 3 ). 3, 8 Consistent with the effect on dopamine neuron activity, the augmented locomotor response to low-dose amphetamine was reversed by vHipp MGE cell transplants (n ¼ 12; t ¼ 3.41; Po0.001). It should also be noted that the live cell transplants had an effect on the locomotor response in salinetreated rats (n ¼ 17; Holm Sidak; t ¼ 4.51; Po0.001), causing an enhanced locomotor response to low-dose amphetamine when compared with saline-treated controls. A similar pattern was observed at the high dose of amphetamine (2.0 mg kg À 1 , i.p.), whereby MAM-treated control rats exhibited an enhanced locomotor response when compared with saline-treated controls, which was also reversed by the MGE cell transplants (three-way ANOVA of 2.0 mg kg À 1 dose; F Strain ¼ 4.80; F Treatment ¼ 10.98; F StrainxTreatment ¼ 18.95; Holm Sidak; t ¼ 4.48; Po0.001).
Immunohistochemistry
Immunohistochemistry was performed postmortem to confirm that the phenotype of the transplanted neurons was consistent with previous characterizations. 20 Thus, a significant proportion of the transplanted cells were positive for GAD65/67 (n ¼ 204 out of 446 GFP þ cells; 45.7%), whereas a much smaller number expressed the calcium-binding protein PV (n ¼ 92 out of 508 GFP þ cells; 18.1%) consistent with previous studies. [18] [19] [20] Taken together, these data indicate that the transplanted cells possess a GABAergic phenotype, and thus posses the ability to increase inhibitory tone within the vHipp.
DISCUSSION
Recent evidence suggests that aberrant hippocampal activity underlies the dysfunction present in the dopamine system of both schizophrenia patients 5, 7, 25 and rodent models of the disorder. 3, 8, 9 We posit that this augmented hippocampal activity is secondary to a decrease in GABAergic neurotransmission, as suggested by both preclinical 9, 11 and clinical studies. 10, 26 Thus, we propose that transplantation of GABAergic precursor cells will restore hippocampal function and normalize downstream alterations in dopamine neuron activity and associated behavior. To examine this hypothesis, we used a rodent model of schizophrenia, the MAM gestational day 17 model. MAM-treated rats consistently display anatomical, physiological and behavioral deficits commonly associated with schizophrenia, thus providing a useful model of the disease. 14 that region, as well as, restore downstream dopamine system function and a behavioral correlate for the positive symptoms of schizophrenia.
MGE cell transplants have been utilized in various rodent models of disease to increase GABAergic inhibition. 15, 18, 27 Transplanted cells are able to survive, migrate, possess a GABAergic phenotype and integrate into the existing brain circuitry. 18, 20 Here we demonstrate that transplanted MGE cells are able to migrate within the hippocampus of both MAM-and saline-treated rats. Furthermore, the transplanted cells were observed at a minimum of 2 months post transplantation and displayed characteristics of mature GABAergic cells. Pertinent to our study, we used immunohistochemical techniques to stain hippocampal brain sections for GAD65/67 and PV. Indeed, a large percentage of the transplanted cells were glutamic acid decarboxylase positive with a smaller percentage positive for PV, consistent with previous studies that characterized the use of MGE tissue grafts in rodent models. 15, 19, 20 It should be noted that although some cells were observed in the pyramidal cell layer, this does not indicate that these were excitatory neurons. Transplanted cells injected into mature rats do not follow the same migratory routes as they would in the developing brain, and it has been previously demonstrated that even cells clearly located in principle cell layers of the hippocampus are GABAergic. 19 As demonstrated previously, vHipp activity is significantly greater in MAM-treated rats. 3, 9 This is consistent with imaging studies in human schizophrenia patients demonstrating greater activity within hippocampal subfields. 7, 28 We believe that the increase in hippocampal activity is attributable to a decrease in interneuron function, particularly those expressing the calciumbinding protein PV. PV interneurons are fast firing, perisomatic targeting neurons that regulate the firing activity of pyramidal neurons in the hippocampus. Moreover, a wealth of clinical 10, 29 and preclinical studies 11, 30 demonstrate reductions in PV expression throughout the cortex and hippocampus. We posit that decreased interneuron function is the cause of the aberrant hippocampal activity in schizophrenia. Indeed, we have previously demonstrated that the enzymatic degradation of the extracellular matrix surrounding vHipp PV interneurons is sufficient to augment hippocampal activity and produce aberrant dopamine system function and behavior. 9 We now demonstrate that the transplantation of MGE-derived GABAergic precursor cells into the vHipp normalizes the augmented activity of pyramidal neurons in MAMtreated rats.
Previous studies have demonstrated that the hippocampus regulates dopaminergic transmission via a multisynaptic pathway involving the nucleus accumbens and ventral pallidum. 31, 32 In addition, we have previously demonstrated that the aberrant hippocampal activity observed in MAM-treated rats is the cause of the augmented dopamine system function. 3, 8 Given that the transplantation of GABAergic precursor cells decreased activity within the vHipp of MAM-treated rats, we predicted that this would also normalize the aberrant ventral tegmental area dopamine neuron activity observed in MAM-treated rats. 3, 8, 13 Indeed, although having no effect in control animals, MGE transplants decreased the number of spontaneously active dopamine neurons in MAM-treated rats to a level consistent with that of control rats, thus demonstrating the feasibility of this approach to normalize aberrant dopamine system function in a model of schizophrenia.
To assess whether this normalization of aberrant dopamine neuron activity translates into alterations in behavior, we performed an amphetamine-induced locomotion study. This behavioral assay is commonly used as a correlate for the positive symptoms associated with schizophrenia. Psychomotor stimulants can induce psychosis in humans, whereas schizophrenia patients are more sensitive to these effects. 1, 33 Consistent with the enhanced sensitivity observed in human patients, animal models of schizophrenia display an enhanced locomotor response to a low-dose of amphetamine when compared with controls. 3, 8, 9, 34 We now demonstrate that this behavioral hyperexcitability can be completely normalized by transplantation of GABAergic precursor cells into the vHipp. It should be noted that MGE transplants produced the opposite effect in saline-treated control animals, that is, an enhanced locomotor response to amphetamine, a finding which is similar to that observed in our recent study utilizing deep brain stimulation to decrease hippocampal function. 8 The reasons underlying this effect are not currently known; however, as we did not observe any changes in dopamine neuron population activity, and only subtle changes in firing rate (Figure 4) , which is likely due to changes in presynaptic dopamine release either from a direct vHipp projection or via a polysynaptic pathway. The exact mechanisms contributing to the augmented locomotor activity in control rats remain to be elucidated.
Taken together, we demonstrate that MGE-derived cells, when transplanted into the vHipp of MAM-treated rats, are able to normalize aberrant pyramidal neuron activity and downstream dopamine system function. In addition, by normalizing vHipp and dopamine neuron activity, the hyper-responsivity to psychomotor stimulants was reversed demonstrating a potential therapeutic effect on positive symptoms. It should be noted that we are not advocating that fetal precursor cells be used for the treatment of schizophrenia; however, recent advances in cell-based therapies have enabled investigators to differentiate stem cells into distinct lineages. Such advances will ultimately lead to the ability to generate GABAergic neurons that may be effective in treating schizophrenia. 
